athenahealth, Inc (NASDAQ:ATHN) CEO Jonathan Bush sold 30,000 shares of the company’s stock in a transaction on Tuesday, December 26th. The shares were sold at an average price of $134.80, for a total transaction of $4,044,000.00. Following the completion of the transaction, the chief executive officer now owns 320,807 shares of the company’s stock, valued at approximately $43,244,783.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Jonathan Bush also recently made the following trade(s):
- On Wednesday, December 26th, Jonathan Bush sold 30,000 shares of athenahealth stock. The stock was sold at an average price of $134.80, for a total transaction of $4,044,000.00.
- On Monday, October 2nd, Jonathan Bush sold 4,000 shares of athenahealth stock. The stock was sold at an average price of $124.17, for a total transaction of $496,680.00.
athenahealth, Inc (ATHN) opened at $129.47 on Friday. athenahealth, Inc has a 1-year low of $95.01 and a 1-year high of $158.66. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67. The stock has a market cap of $5,181.13, a PE ratio of 109.72, a price-to-earnings-growth ratio of 3.03 and a beta of 1.58.
athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The company had revenue of $304.60 million during the quarter, compared to analysts’ expectations of $310.52 million. During the same period last year, the company posted $0.60 earnings per share. The firm’s quarterly revenue was up 10.1% compared to the same quarter last year. equities research analysts anticipate that athenahealth, Inc will post 1.22 EPS for the current year.
Institutional investors and hedge funds have recently modified their holdings of the company. The Manufacturers Life Insurance Company increased its stake in shares of athenahealth by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after purchasing an additional 84 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in shares of athenahealth by 123.8% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after purchasing an additional 744 shares in the last quarter. ProShare Advisors LLC purchased a new position in shares of athenahealth during the 2nd quarter worth approximately $205,000. Ameriprise Financial Inc. purchased a new position in shares of athenahealth during the 2nd quarter worth approximately $206,000. Finally, Columbia Partners L L C Investment Management purchased a new position in shares of athenahealth during the 2nd quarter worth approximately $216,000.
Several equities research analysts have recently weighed in on ATHN shares. Cantor Fitzgerald reiterated a “hold” rating and set a $120.00 target price on shares of athenahealth in a research note on Friday, October 27th. KeyCorp reiterated a “buy” rating and set a $170.00 target price on shares of athenahealth in a research note on Sunday, September 17th. BidaskClub upgraded shares of athenahealth from a “strong sell” rating to a “sell” rating in a research note on Saturday, December 2nd. Deutsche Bank started coverage on shares of athenahealth in a research note on Friday, December 8th. They set a “hold” rating and a $145.00 target price for the company. Finally, Leerink Swann decreased their target price on shares of athenahealth from $155.00 to $125.00 and set a “market perform” rating for the company in a research note on Monday, October 23rd. One investment analyst has rated the stock with a sell rating, seventeen have given a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $143.96.
TRADEMARK VIOLATION WARNING: “Insider Selling: athenahealth, Inc (NASDAQ:ATHN) CEO Sells 30,000 Shares of Stock” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/14/athenahealth-inc-athn-ceo-jonathan-bush-sells-30000-shares.html.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.